// App-Quantinova.ai

: VENTRICULAR REMODELING IN EARLY STAGE BREAST CANCER PATIENTS RECEIVING SEQUENTIAL ANTHRACYCLINE AND TRASTUZUMAB THERAPY: A CARDIAC MRI STUDY

Researchers

Presenter

  • Mustafa Abdul Selam

Principal Investigators

  • Eitan Amir

  • Christine Brezden-Masley

  • Kim Connelly

  • Maria Michalowska

  • Bernd J. Wintersperger

  • Paaladinesh Thavendiranathan

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved